Chlamydia psittaci Antibody, IgG
Use
Chlamydia psittaci is a bacterium that mainly infects birds but can occasionally infect humans, leading to a respiratory illness known as psittacosis. This test is used to detect the presence of IgG antibodies against Chlamydia psittaci in the blood, indicating a current or past infection. Psittacosis can lead to serious health problems, especially in individuals with weakened immune systems, and may require antibiotic treatment. Detecting antibodies helps in diagnosing the infection and guiding appropriate management for affected patients.
Special Instructions
Ensure proper specimen collection and storage to maintain the integrity of the sample. Use a red-top tube or gel-barrier tube for collecting the serum specimen. This test is not FDA-cleared but is performed under lab-developed protocols.
Limitations
This test is specific for Chlamydia psittaci IgG antibodies and should not be used as the sole criterion for clinical diagnosis. Results need to be interpreted in the context of the patient's clinical presentation and other diagnostic tools. The test has not been cleared or approved by the FDA, as such clearance or approval is not required for lab-developed tests. Performance may vary, and additional confirmatory or reflex tests may be necessary for conclusive diagnosis.
Methodology
Microarray
Biomarkers
LOINC Codes
- 6916-1
- 6916-1
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.15 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Refrigerate
Other tests from different labs that may be relevant